BEAM
Price
$21.72
Change
+$0.77 (+3.68%)
Updated
Jul 25 closing price
Capitalization
2.18B
15 days until earnings call
GLSI
Price
$11.57
Change
+$0.08 (+0.70%)
Updated
Jul 25 closing price
Capitalization
154.67M
14 days until earnings call
Interact to see
Advertisement

BEAM vs GLSI

Header iconBEAM vs GLSI Comparison
Open Charts BEAM vs GLSIBanner chart's image
Beam Therapeutics
Price$21.72
Change+$0.77 (+3.68%)
Volume$1.62M
Capitalization2.18B
Greenwich LifeSciences
Price$11.57
Change+$0.08 (+0.70%)
Volume$37.27K
Capitalization154.67M
BEAM vs GLSI Comparison Chart in %
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. GLSI commentary
Jul 28, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and GLSI is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 28, 2025
Stock price -- (BEAM: $21.72 vs. GLSI: $11.57)
Brand notoriety: BEAM and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 79% vs. GLSI: 65%
Market capitalization -- BEAM: $2.18B vs. GLSI: $154.67M
BEAM [@Biotechnology] is valued at $2.18B. GLSI’s [@Biotechnology] market capitalization is $154.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 1 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 1 green, 4 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 6 TA indicator(s) are bullish while GLSI’s TA Score has 6 bullish TA indicator(s).

  • BEAM’s TA Score: 6 bullish, 3 bearish.
  • GLSI’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, BEAM is a better buy in the short-term than GLSI.

Price Growth

BEAM (@Biotechnology) experienced а +4.67% price change this week, while GLSI (@Biotechnology) price change was -0.17% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BEAM($2.18B) has a higher market cap than GLSI($155M). GLSI YTD gains are higher at: 3.028 vs. BEAM (-12.419). GLSI has higher annual earnings (EBITDA): -16.75M vs. BEAM (-399.03M). BEAM has more cash in the bank: 1.22B vs. GLSI (2.75M). BEAM has higher revenues than GLSI: BEAM (63.6M) vs GLSI (0).
BEAMGLSIBEAM / GLSI
Capitalization2.18B155M1,409%
EBITDA-399.03M-16.75M2,382%
Gain YTD-12.4193.028-410%
P/E RatioN/AN/A-
Revenue63.6M0-
Total Cash1.22B2.75M44,364%
Total Debt158MN/A-
TECHNICAL ANALYSIS
Technical Analysis
BEAMGLSI
RSI
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
80%
MACD
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 3 days ago
80%
Advances
ODDS (%)
Bullish Trend 5 days ago
79%
Bullish Trend 11 days ago
76%
Declines
ODDS (%)
N/A
Bearish Trend 13 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
89%
Aroon
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FPCGX27.490.21
+0.77%
Fort Pitt Capital Total Return
CSCCX26.870.20
+0.75%
Calvert Small-Cap C
TRIHX73.410.35
+0.48%
Nuveen Large Cap Gr Idx I
SEEHX29.480.12
+0.41%
Steward Values Enhanced Lg Cap R6
FCGCX20.03-0.05
-0.25%
Fidelity Advisor Global Commodity Stk C

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+3.68%
CRSP - BEAM
70%
Closely correlated
-1.97%
NTLA - BEAM
65%
Loosely correlated
+6.38%
RXRX - BEAM
63%
Loosely correlated
+3.67%
DNLI - BEAM
62%
Loosely correlated
-4.47%
SYRE - BEAM
58%
Loosely correlated
+1.08%
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
+0.70%
ABOS - GLSI
51%
Loosely correlated
N/A
IMNM - GLSI
48%
Loosely correlated
-3.29%
DNLI - GLSI
48%
Loosely correlated
-4.47%
CLDX - GLSI
47%
Loosely correlated
+0.56%
BEAM - GLSI
47%
Loosely correlated
+3.68%
More